Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliana Trink

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathwayRuixin Liu, Dingxie Liu, Eliana Trink, et al.
Journal of Pharmacy & Bioallied Sciences|January 25, 2014
Thermal latency studies in opiate-treated miceNoam Schildhaus, Eliana Trink, Chirs Polson, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathwayRuixin Liu, Dingxie Liu, Eliana Trink, et al.
Journal of Pharmacy & Bioallied Sciences|January 25, 2014
Thermal latency studies in opiate-treated miceNoam Schildhaus, Eliana Trink, Chirs Polson, et al.
Pageof 1